Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness
harpenz / Pixabay

Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness

According to a story from Charcot-Marie-Tooth Disease News, Charcot-Marie-Tooth disease is actually somewhat common in the US compared to other rare diseases. In fact, it is estimated that around 150,000…

Continue Reading Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness
Possible Treatment for WHIM Syndrome Earns Orphan Drug Designation in the EU
Free-Photos / Pixabay

Possible Treatment for WHIM Syndrome Earns Orphan Drug Designation in the EU

According to a story from home.suddenlink.net, the biopharmaceutical company X4 Pharmaceuticals recently announced that the European Commission has granted Orphan Drug designation to the company's lead investigational drug candidate, mavorixafor.…

Continue Reading Possible Treatment for WHIM Syndrome Earns Orphan Drug Designation in the EU
Researchers Discover “Testicular Cancer-Associated Paraneoplastic Encephalitis,” an Autoimmune Disease
derneuemann / Pixabay

Researchers Discover “Testicular Cancer-Associated Paraneoplastic Encephalitis,” an Autoimmune Disease

According to a story from Cancer Health, a team of scientists affiliated with Mayo Clinic, UC San Francisco, and the Chan Zuckerburg Biohub have discovered a new rare, autoimmune disease…

Continue Reading Researchers Discover “Testicular Cancer-Associated Paraneoplastic Encephalitis,” an Autoimmune Disease
Experimental Treatment for Neurofibromatosis Type 1 Earns Orphan Drug Designation in the EU
pixel2013 / Pixabay

Experimental Treatment for Neurofibromatosis Type 1 Earns Orphan Drug Designation in the EU

According to a story from BioPortfolio, the biopharmaceutical company SpringWorks Therapeutics, Inc., has recently announced that the European Commission has given the company's investigational drug candidate mirdametinib Orphan Drug designation.…

Continue Reading Experimental Treatment for Neurofibromatosis Type 1 Earns Orphan Drug Designation in the EU
Company Seeks to Treat Hunter Syndrome (MPS II) in China With New Drug Application
liaoyiye / Pixabay

Company Seeks to Treat Hunter Syndrome (MPS II) in China With New Drug Application

According to a story from BioSpace, the biopharmaceutical company CANBridge Pharmaceuticals announced that it has recently submitted a New Drug Application with China's National Medicinal Products Administration (NMPA) for its…

Continue Reading Company Seeks to Treat Hunter Syndrome (MPS II) in China With New Drug Application
Experimental Treatment for Primary Biliary Cholangitis Earns Orphan Drug Status in the US and EU
Aymanejed / Pixabay

Experimental Treatment for Primary Biliary Cholangitis Earns Orphan Drug Status in the US and EU

According to a story from Markets Insider, the biopharmaceutical company GENFIT recently announced that both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have awarded…

Continue Reading Experimental Treatment for Primary Biliary Cholangitis Earns Orphan Drug Status in the US and EU
Advocates for Duchenne Muscular Dystrophy Start Company Designed to Collect Data Directly From Patients
rawpixel / Pixabay

Advocates for Duchenne Muscular Dystrophy Start Company Designed to Collect Data Directly From Patients

According to a story from Xconomy, the US Food and Drug Administration (FDA) made a controversial decision three years ago when it approved the drug eteplirsen as a treatment for…

Continue Reading Advocates for Duchenne Muscular Dystrophy Start Company Designed to Collect Data Directly From Patients
Study Finds Repeated Transsphenoidal Surgery Effective in Treating Cushing’s Disease
geudki / Pixabay

Study Finds Repeated Transsphenoidal Surgery Effective in Treating Cushing’s Disease

According to a story from Cushing's Disease News, a recent study has confirmed that repeated transsphenoidal surgery can be effective in treating Cushing's disease in patients that have experienced remission…

Continue Reading Study Finds Repeated Transsphenoidal Surgery Effective in Treating Cushing’s Disease

FDA Advisory Committee Recommends Approval of Drug to Treat Interstitial Lung Disease Caused by Systemic Sclerosis

According to a story from Healio, the US Food and Drug Administration's (FDA) Arthritis Advisory Committee recently voted 10-7 in favor of recommending the drug nintedanib as a treatment for…

Continue Reading FDA Advisory Committee Recommends Approval of Drug to Treat Interstitial Lung Disease Caused by Systemic Sclerosis
Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows
cherylholt / Pixabay

Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows

According to a story from Angioedema News, a recent clinical trial has demonstrated that the drug conestat alfa (marketed as Ruconest) was able to successfully treat 96 percent of acute…

Continue Reading Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows

Study Findings Result in New Diagnostic Recommendations for Hereditary Angioedema in the ER

According to a story from Angioedema News, a team of researchers has used data from a recent study to provide up to date recommendations for diagnosing hereditary angioedema in the…

Continue Reading Study Findings Result in New Diagnostic Recommendations for Hereditary Angioedema in the ER
Scleroderma: The Skin-Hardening Disease Affecting Two UK Sisters
https://pixabay.com/en/sunset-sun-sisters-girl-shadow-929179/

Scleroderma: The Skin-Hardening Disease Affecting Two UK Sisters

An article from Comic Sands recently covered the story of a UK mother, Alison Beesley, who is now committed to taking care of her daughters Eliza and Eleanor full time. Eliza is nine years old and…

Continue Reading Scleroderma: The Skin-Hardening Disease Affecting Two UK Sisters

Experimental Treatment for Acute Myeloid Leukemia Earns Orphan Drug Designation

According to a story from globenewswire.com, the biopharmaceutical company Mustang Bio, Inc. has recently announced that the US Food and Drug Administration (FDA) has recently awarded the company Orphan Drug…

Continue Reading Experimental Treatment for Acute Myeloid Leukemia Earns Orphan Drug Designation
New Biosimilar to Rituxan Earns FDA Approval
source: pixabay.com

New Biosimilar to Rituxan Earns FDA Approval

According to a story from drugs.com, the pharmaceutical company Pfizer, Inc. recently issued an announcement detailing the approval of its drug Ruxience (rituximab-pvvr), a biosimilar to the widely used monoclonal…

Continue Reading New Biosimilar to Rituxan Earns FDA Approval
India Turns to Enzyme Replacement Therapy as it Seeks to Address Rare Diseases
klbz / Pixabay

India Turns to Enzyme Replacement Therapy as it Seeks to Address Rare Diseases

According to a story from health.economictimes.indiatimes.com, the country of India is currently beginning to take more steps in order to address the dire unmet medical need of its rare disease…

Continue Reading India Turns to Enzyme Replacement Therapy as it Seeks to Address Rare Diseases
Positive Preliminary Safety Findings in Phase 2 Hepatocellular Carcinoma Trial
DarkoStojanovic / Pixabay

Positive Preliminary Safety Findings in Phase 2 Hepatocellular Carcinoma Trial

According to a story from BioPortfolio, the biotechnology company Tiziana Life Sciences plc has announced the release of preliminary topline data findings from its phase 2a clinical trial, which tested…

Continue Reading Positive Preliminary Safety Findings in Phase 2 Hepatocellular Carcinoma Trial
Extension Trial Finds That Orenitram Improves Walking Distance in Pulmonary Arterial Hypertension
Fotorech / Pixabay

Extension Trial Finds That Orenitram Improves Walking Distance in Pulmonary Arterial Hypertension

According to a story from Pulmonary Arterial Hypertension News, data from an open label extension trial of the drug Orenitram as a treatment for pulmonary arterial hypertension has demonstrated that…

Continue Reading Extension Trial Finds That Orenitram Improves Walking Distance in Pulmonary Arterial Hypertension